Novel mutations (γTrp208Leu and γLys232Thr) leading to congenital hypofibrinogenemia in two unrelated Chinese families
Autor: | Yingyu Wang, Yaosheng Xie, Hongxiang Ding, Misheng Zhao, Xiuping Hao, Haixiao Xie, Liqing Zhu, Mingshan Wang |
---|---|
Rok vydání: | 2014 |
Předmět: |
Proband
Adult Male medicine.medical_specialty Heterozygote Thrombin Time DNA Mutational Analysis Thrombin time Fibrinogen medicine.disease_cause Exon Asian People Lymphadenitis Internal medicine medicine Humans Child Prothrombin time Mutation medicine.diagnostic_test Transition (genetics) business.industry Hematology General Medicine Exons Hypofibrinogenemia Afibrinogenemia Pedigree Endocrinology Prothrombin Time Female business medicine.drug |
Zdroj: | Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 25(8) |
ISSN: | 1473-5733 |
Popis: | Congenital hypofibrinogenemia is a rare disorder caused by heterozygous mutations in the fibrinogen genes. The aim of this study was to elucidate the molecular defects in two unrelated families with hypofibrinogenemia. The proband from family A was a 19-year-old Chinese boy who was suffering from cervical lymphadenitis. A low plasma fibrinogen concentration (0.63 g/l by Clauss method and 0.77 g/l by immunoturbidimetry) was found in routine clotting tests. Further gene analysis revealed a heterozygous g.5792 G>T mutation in exon 7 of the FGG, leading to a novel Trp208Leu change in the γ D domain. This mutation was also found in other family members with low fibrinogen levels. The proposita from family B was a 37-year-old female who suffered from recurrent shoulder pain for 7 years. Routine clotting studies revealed that her prothrombin time was 15.5 s (normal range: 11.8-14.8 s) and thrombin time was 22.8 s (normal range: 14.0-20.0 s), and the fibrinogen concentration in her plasma was only 0.64 g/l by Clauss method and 0.79 g/l by immunoturbidimetry. A heterozygous A>C transition at nucleotide 5864 of FGG was found in the γ chain, causing a Lys232Thr substitution in the fibrinogen. Further sequencing established that her mother, son, brother and nephew were also heterozygous for the mutation. |
Databáze: | OpenAIRE |
Externí odkaz: |